{
    "Trade/Device Name(s)": [
        "Calcium ADVANCE Assay",
        "Calcium-ADVANCE Assay"
    ],
    "Submitter Information": "Diagnostic Chemicals Limited",
    "510(k) Number": "K051757",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CJY"
    ],
    "Summary Letter Date": "October 27, 2005",
    "Summary Letter Received Date": "October 28, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1145"
    ],
    "Regulation Name(s)": [
        "Calcium test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total Calcium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (Lithium Heparin)",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Calcium ADVANCE Assay for quantitative determination of total calcium in serum, plasma, and urine",
    "Indications for Use Summary": "For the quantitative determination of Total Calcium in serum, plasma (Lithium Heparin) and urine for in vitro diagnostic use",
    "fda_folder": "Clinical Chemistry"
}